ENTITY
Jafron Biomedical

Jafron Biomedical (300529 CH)

32
Analysis
Health Care • China
Jafron Biomedical Co., Ltd. manufactures biomaterials and medical devices. The Company researches, produces, and sells immunization adsorption, resin hemoperfusion, blood purification, resin bandage, and other related products. Jafron Biomedical markets throughout China.
more
•07 Aug 2026 15:04

Primer: Jafron Biomedical (300529 CH) - Aug 2026

Jafron Biomedical is the dominant market leader in China's hemoperfusion industry, holding over 70% market share with its proprietary...

Logo
86 Views
Share
•28 May 2026 13:30

Quiddity Leaderboard ChiNext & ChiNext 50 Jun26: Final Expectations; US$1bn+ Combined One-Way Flows

The ChiNext/ChiNext 50 Jun26 index review results will be announced publicly in the next few days. In this insight, we have presented our final...

Share
•15 Apr 2026 18:35

Quiddity Leaderboard ChiNext & ChiNext 50 Jun26: Reference Period Ending Soon; Ranks Still Not Final

Two of our ChiNext expected DELs can still escape deletion if they strongly outperform other names in the next couple of weeks. If that happens, a...

Share
•20 Mar 2026 19:02

Quiddity Leaderboard ChiNext & ChiNext 50 Jun26: Expected ADDs/DELs Can Change; US$1bn+ One-Way

We expect there to be US$899mn and US$216mn one-way flows for the ChiNext and ChiNext 50 in June 2026. Some names have double impacts.

Share
•12 Feb 2026 19:36

Quiddity Leaderboard ChiNext & ChiNext 50 Jun26: Some Changes to Expectations

We see one-way flows of US$1.2bn and US$341mn for the ChiNext index and ChiNext 50 index respectively. Some names have multiple days of volume to...

Share
x